From The Owner

CELLINK has entered into an agreement to acquire precision dispensing company Scienion Ag

ELLINK AB (publ) (“CELLINK”) has entered into an agreement with the owners of Scienion Ag (“Scienion”), a German life science company focusing on precision dispensing technologies, to acquire all shares for a purchase price on cash- and debt-free basis of 80M euros (the “Acquisition”). 40M euros will be paid in 2,814,032 newly issued shares of series B in CELLINK (the “Consideration Shares”) and the reminder in cash.